Nykode Therapeutics
Biotechnology ResearchOslo, Norway51-200 Employees
We are a leading technology platform that unlocks unlimited possibilities for the future of medicine through our intelligent modular design and tailored hyper targeting.
Insights
Immunotherapy Advancements Nykode Therapeutics is making significant advancements in immunotherapy through the development of antigen-specific treatments for autoimmune diseases and the launch of updates to the inverse vaccine platform. These innovations present promising sales opportunities in the biotechnology and pharmaceutical sectors.
Strategic Partnerships Collaborations with key players like Keytruda and Roche showcase Nykode's ability to form strategic partnerships in the healthcare industry. Leveraging these alliances can open doors for joint sales efforts and expanded market reach.
Strong Financial Standing With a successful IPO raising $45.1 million and a revenue range of $10-50 million, Nykode Therapeutics demonstrates financial stability and growth potential. This solid financial standing enhances the company's credibility and attractiveness to potential investors and partners.
Market Expansion Opportunities Nykode's focus on developing vaccines against cancer and infectious diseases, coupled with its presence in Oslo, provides an excellent platform for exploring new markets and expanding global sales reach. Targeting regions with high demand for cancer treatments can be a lucrative sales strategy.
Competitive Edge Being a pioneer in the neoantigen cancer vaccine space and having partnerships with renowned companies like Regeneron, Nykode Therapeutics has a competitive edge in the biotechnology research industry. Highlighting these strengths in sales pitches can help differentiate the company and attract potential clients.
Similar companies to Nykode Therapeutics
Chimeric Therapeutics
12
$10MCybrexa Therapeutics
20$10MImmco Diagnostics
51$10M$50MAro Biotherapeutics
50$10M
Nykode Therapeutics Tech Stack
Nykode Therapeutics uses 8 technology products and services including Cookie Notice, CookieYes, Microsoft 365, and more. Explore Nykode Therapeutics's tech stack below.
- Cookie NoticeCookie Compliance
- CookieYesCookie Compliance
- Microsoft 365Email
- AOSJavascript Libraries
- Amazon ALBLoad Balancers
- Open GraphMiscellaneous
- Microsoft AzurePlatform As A Service
- Yoast SEOSearch Engines
Media & News
Nykode Therapeutics's Email Address Formats
Nykode Therapeutics uses at least 2 format(s):
| Nykode Therapeutics Email Formats | Percentage |
| FLast@vaccibody.com | 55% |
| F.Last@vaccibody.com | 14% |
| FMLast@vaccibody.com | 7% |
| FL@vaccibody.com | 6% |
| First.Last@vaccibody.com | 5% |
| FMiddleLast@vaccibody.com | 4% |
| FirstLast@vaccibody.com | 2% |
| First.L@vaccibody.com | 2% |
| First.Middle.Last@vaccibody.com | 1% |
| FirstLas@vaccibody.com | 1% |
| LFirst@vaccibody.com | 1% |
| First_Last@vaccibody.com | 1% |
| LastFir@vaccibody.com | 1% |
| FLast@nykode.com | 67% |
| FLast@nykode.com | 16% |
| FLast@nykode.com | 17% |
Frequently Asked Questions
Where is Nykode Therapeutics's headquarters located?
Nykode Therapeutics's main headquarters is located at Gaustadalléen 21 Oslo, 0349 NO. The company has employees across 2 continents, including EuropeNorth America. What is Nykode Therapeutics's official website and social media links?
Nykode Therapeutics's official website is nykode.com and has social profiles on LinkedIn.How much revenue does Nykode Therapeutics generate?
As of October 2024, Nykode Therapeutics's annual revenue reached $35M. What is Nykode Therapeutics's SIC code NAICS code?
Nykode Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Nykode Therapeutics have currently?
As of October 2024, Nykode Therapeutics has approximately 185 employees across 2 continents, including EuropeNorth America. Key team members include Chief Development Officer: K. E.Chief Business Officer: A. F.Chief Financial Officer: H. G.. Explore Nykode Therapeutics's employee directory with LeadIQ.What industry does Nykode Therapeutics belong to?
Nykode Therapeutics operates in the Biotechnology Research industry. What technology does Nykode Therapeutics use?
Nykode Therapeutics's tech stack includes Cookie NoticeCookieYesMicrosoft 365AOSAmazon ALBOpen GraphMicrosoft AzureYoast SEO. What is Nykode Therapeutics's email format?
Nykode Therapeutics's email format typically follows the pattern of . Find more Nykode Therapeutics email formats with LeadIQ. How much funding has Nykode Therapeutics raised to date?
As of October 2024, Nykode Therapeutics has raised $25M in funding. The last funding round occurred on Dec 16, 2016 for $25M.When was Nykode Therapeutics founded?
Nykode Therapeutics was founded in 2007.
Company Overview
- Headquarters
- Gaustadalléen 21 Oslo, 0349 NO
- Website
- nykode.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2007
- Employees
- 51-200
Media & News
Funding & Financials
- $25M
Nykode Therapeutics has raised a total of $25M of funding over 4 rounds. Their latest funding round was raised on Dec 16, 2016 in the amount of $25M.
- $10M$50M
Nykode Therapeutics's revenue is in the range of $10M$50M
Funding & Financials
- $25M
Nykode Therapeutics has raised a total of $25M of funding over 4 rounds. Their latest funding round was raised on Dec 16, 2016 in the amount of $25M.
- $10M$50M
Nykode Therapeutics's revenue is in the range of $10M$50M
Company Leadership
K. E.Chief Development Officer
A. F.Chief Business Officer- H. G.Chief Financial Officer
S. T.Chief Medical Officer- H. S.Chief Accounting Officer
Employee Directory
- H. G.Chief Financial Officer
- M. H.Cto
- S. T.Chief Medical Officer
- H. S.Chief Accounting Officer
- M. N.Chairman Of The Board
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
